ADMA Biologics
ADMA
#4061
Rank
C$4.18 B
Marketcap
C$18.88
Share price
-1.27%
Change (1 day)
-22.05%
Change (1 year)

Earnings for ADMA Biologics (ADMA)

Earnings in 2026 (TTM): C$0.34 Billion

According to ADMA Biologics 's latest financial reports the company's current earnings are C$0.51 Billion. In 2025 the company made an earning of C$0.27 Billion, an increase over its 2024 earnings that were of C$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADMA Biologics from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.34 B26.21%
2025 C$0.27 B35.89%
2024 C$0.20 B-4446.66%
2023 -C$4.61 Million-93.11%
2022 -C$66.86 Million-20.42%
2021 -C$84.02 Million-8.11%
2020 -C$91.44 Million62.31%
2019 -C$56.34 Million-34.76%
2018 -C$86.36 Million48.79%
2017 -C$58.04 Million134.28%
2016 -C$24.78 Million7.12%
2015 -C$23.13 Million0.3%
2014 -C$23.06 Million7.85%
2013 -C$21.38 Million71.04%
2012 -C$12.5 Million28864%
2011 -C$0.05 Million35.22%
2010 -C$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
C$43.98 M-87.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-C$0.33 Billion-191.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$31.92 Million-109.08%๐Ÿ‡บ๐Ÿ‡ธ USA